Request Demo
Last update 24 May 2025
CLL1-CD33 cCART cell therapy (iCell Gene Therapeutics)
Last update 24 May 2025
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms CLL1-CD33 cCAR T cells (iCell Gene Therapeutics), CLL1-CD33 cCART cell therapy, CLL1-CD33-CCAR |
Target |
Action modulators |
Mechanism CD33 modulators(Myeloid cell surface antigen CD33 modulators), CLL-1 modulators(C-Type lectin domain family 12 member A modulators), Gene transference(Gene transference) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingEarly Phase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CLL1-CD33 cCART cell therapy (iCell Gene Therapeutics)NCT03795779
Phase I, Interventional, Single Arm, Open Label, Treatment Study to Evaluate The Safety and Tolerability of CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies.
100 Clinical Results associated with CLL1-CD33 cCART cell therapy (iCell Gene Therapeutics)
Login to view more data
100 Translational Medicine associated with CLL1-CD33 cCART cell therapy (iCell Gene Therapeutics)
Login to view more data
100 Patents (Medical) associated with CLL1-CD33 cCART cell therapy (iCell Gene Therapeutics)
Login to view more data
100 Deals associated with CLL1-CD33 cCART cell therapy (iCell Gene Therapeutics)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Phase 1 | China | 01 Mar 2018 | |
| Anemia, Refractory, With Excess of Blasts | Phase 1 | China | 01 Mar 2018 | |
| Chronic Myelogenous Leukemia | Phase 1 | China | 01 Mar 2018 | |
| Myeloproliferative Disorders | Phase 1 | China | 01 Mar 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free